Can someone remind me why IMU is ONLY trialling late stage patients who have been through chemo (a couple of times?) and possibly having hugely compromised immune systems? Or my memory is failing me here and this is not the case?
Why can't stage 1 or 2 patients be trialled and thus no need to go through chemo and the cancer tumour are cured via direct injections. It would still be a worthy blockbuster, right?
TIA
***not saying the current trials are not going well, mind you.
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-196
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.003(5.36%) |
Mkt cap ! $431.8M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 6.1¢ | 5.6¢ | $1.239M | 21.07M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 1459482 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 633310 | 6 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |